How to structure your company to make it attractive to U.S. and China investors and provide rule-of-law and shareholder rights
How to secure China, U.S. and international patents that provide freedom to operate while blocking your competition
How to leverage China CROs to outsource pre-clinical and clinical development to minimize costs and maximize return on investment
How to position your company to attract investment from many of the private and government funding sources available in China as well as the U.S.
Who Should Attend
Join other key executives and managers of biotechnology and life science companies interested in learning how to leverage China to raise investment funds, develop new drugs or medical devices, and generate global intellectual property rights.
Learn “how to do it” from our speakers who are all senior executives who have successfully put their principles into practice in the real world. Also meet other executives and managers from companies facing the same issues as you.
Agenda
|
Time
|
Topic
|
Speaker
|
|
08:00-08:30
|
Registration, Refreshments
|
Sponsored by WSGR
|
|
08:30-08:40
|
Welcome, Opening Remarks
|
TBD
|
|
08:40-09:20
|
Structuring a Global Biomedical Co.
|
TBD
|
|
09:20-10:00
|
Building a Global Patent Portfolio
|
TBD
|
|
10:00-10:30
|
Networking Break, Refreshments
|
Sponsored by WSGR
|
|
10:30-11:10
|
Reducing Drug Development Costs
|
John V. Olyer, MBA – BioDuro, Inc.
|
|
11:10-11:50
|
Attracting Investment Capital
|
Greg B. Scott – ChinaBio® Accelerator
|
|
11:50-12:00
|
Closing Remarks |
Greg B. Scott – ChinaBio® Accelerator |
| 11:50-12:00 |
Networking, Refreshments
|
Sponsored by WSGR |
Speaker Biographies
|
Greg B. Scott – President and Founder, ChinaBio® Accelerator
|
 |
Mr. Scott has helped launch over thirty life science startups in the US and China as a founder, investor and advisor. He founded the ChinaBio® Accelerator to help fund and mentor early stage life science companies in China. Mr. Scott is also the president and co-founder of Life Science Angels, and executive editor of ChinaBio® Today. Mr. Scott previously held senior management positions with PricewaterhouseCoopers, Capgemini and MCI. |
|
John V. Olyer, MBA – President and CEO, BioDuro, Inc.
|
 |
John is a serial entrepreneur with a track record of success who has started and managed numerous companies and raised over $US225 million in capital. In the biotech field John started (or re-started, in the case of Genta) 4 companies: Galenea (private), Genta (Nasdaq – GNTA; co-CEO), Walden Laboratories (merged into Indeveus –IDEV, VP of Operations), Oasis Biosciences (sold to Genprobe -GPRO). Mr.Oyler holds a BS in Engineering from The Massachusetts Institute of Technology and a MBA from Stanford Business School.
|
Location
This ChinaBio® Executive Workshop will be held at:
Wilson Sonsini Goodrich & Rosati
12235 El Camino Real #200
San Diego, CA
Tel: 858-350-2300
Directions
From San Diego Airport (Interstate 5 North)
Take Interstate 5 North to Carmel Valley Road. Exit Carmel Valley Road right, heading east. Turn left onto El Camino Real and go .5 mi. Turn right into the Carmel Valley Corporate Center. Then make the first left to get to 12235 (KB Homes bldg). WSGR is located on the 2nd floor.
From LA/Irvine (Interstate 5 South)
Take Interstate 5 South to Carmel Valley Road. Exit Carmel Valley Road left, heading east. Turn left onto El Camino Real and go .5 mi. Turn right into the Carmel Valley Corporate Center. Then make the first left to get to 12235 (KB Homes bldg). WSGR is located on the 2nd floor.
Workshop Sponsors
We would like to thank the following sponsors for making this event possible:
BioBay – BioBay, the fastest growing life science park in China, is located in the Suzhou Industrial Park (SIP), a cooperative program between China and Singapore. BioBay plays a key role as the innovation base for SIP to cultivate biotechnology industry and also an innovation platform for the biotechnology and nanotechnology development of both Suzhou city and China. www.biobay.com.cn
Wilson Sonsini Goodrich & Rosati – Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology and growth enterprises worldwide, as well as the investment banks and venture capital firms that finance them. Over the past four decades, Wilson Sonsini Goodrich & Rosati has established its reputation in life science by having an unmatched knowledge of and deep and long-standing contacts in the industry.www.wsgr.com
BIOCOM – BIOCOM is a leading biotechnology industry association with over 550 leading life science companies from Southern California as members. BIOCOM's initiatives focus on capital formation, public policy, resource development and scientific discovery and development. They have recently launched a special program to educate and connect U.S.-based life science companies with low cost resources and services available in China. www.biocom.org
SABPA – Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA) is a 501(C) (3) nonprofit organization founded in early 2002 by professionals and scholars from local Chinese community in San Diego. We invite all scholars, students and professionals with any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry to join us as members of SABPA. www.sabpa.org
ChinaBio® Today – ChinaBio® Today is an email and web newsletter focused on the rapidly evolving life science industry in China. From our offices in Shanghai and California, we provide daily news, commentary and analysis on public and private China biotech companies and industry events. Free email subscriptions are available at www.ChinaBioToday.com.
About ChinaBio® Accelerator
ChinaBio® Accelerator was created to accelerate the globalization of China's biotechnology industry by:
· Providing early stage funding to China life science companies;
· Increasing China entrepreneurs’ success rate by mentoring and providing strategic support;
· Developing business partnership and sales development opportunities with the West; and
· Expanding professional networks through introductions to investors, partners, customers and media.
ChinaBio is identifying promising biotech and medical device investment opportunities in China and providing the capital, connections and leadership to help entrepreneurs realize their vision. www.ChinaBioLLC.com.
